These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12139875)

  • 1. [Chilhood hepatic fascioliasis treated with triclabendazol].
    Iglesias Escalera G; Elvira Pardilla AI; Rodrigo Palacios J; Merino Arribas JM; Marrero Calvo M; García Bravo M; Vegas Alvarez AM
    An Esp Pediatr; 2002 Aug; 57(2):171-2. PubMed ID: 12139875
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of hepatic fascioliasis treated with Cloxyl].
    Belchiţă A; Dăncescu P; Dudu S; Lăzărescu M; Rafael-Stefănescu G; Tiţeica M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):377-81. PubMed ID: 30156
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic fascioliasis resistant to bithionol treatment but responsive to triclabendazole].
    Medrano F; de Tomás E; Barba MA; Alamillo A; Ferreras P
    Enferm Infecc Microbiol Clin; 1999; 17(7):371-2. PubMed ID: 10535200
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human fascioliasis with atypical severe presentation. Treatment with triclabendazole].
    Merino Alonso J; Amérigo García MJ; Alvarez Rubio L; Erdozaín Ruiz I
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):28-30. PubMed ID: 9542306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fasciolosis: a study on the relation of infection intensity and treatment to hepatobiliary affection.
    Osman MM; Ismail Y; Aref TY
    J Egypt Soc Parasitol; 1999 Aug; 29(2):353-63. PubMed ID: 10605489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of human fascioliasis with triclabendazole: good news.
    Curtale F
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):508. PubMed ID: 18346770
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam.
    Hien TT; Truong NT; Minh NH; Dat HD; Dung NT; Hue NT; Dung TK; Tuan PQ; Campbell JI; Farrar JJ; Day JN
    Am J Trop Med Hyg; 2008 Mar; 78(3):388-92. PubMed ID: 18337331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stomach ache and fever after consumption of watercress in Turkey: fascioliasis].
    van Daele PL; Madretsma GS; van Agtmael MA
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1896-9. PubMed ID: 11605314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe eosinophilia and hepatic lesion: a rare case of fascioliasis from Greece.
    Assimakopoulos SF; Psilopanagioti A; Michail A; Papakonstantinou C; Gogos C; Labropoulou-Karatza C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):125. PubMed ID: 20593041
    [No Abstract]   [Full Text] [Related]  

  • 10. Conservative management of biliary obstruction due to Fasciola hepatica.
    Mannstadt M; Sing A; Leitritz L; Brenner-Maucher K; Bogner J
    Clin Infect Dis; 2000 Nov; 31(5):1301-3. PubMed ID: 11073771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of triclabendazole against Fasciola gigantica in buffaloes in eastern Nepal.
    Mahato SN; Harrison LJ; Hammond JA
    Vet Rec; 1994 Dec; 135(24):579-80. PubMed ID: 7886900
    [No Abstract]   [Full Text] [Related]  

  • 12. Human fascioliasis treated with triclabendazole (Fasinex) for the first time.
    Wessely K; Reischig HL; Heinerman M; Stempka R
    Trans R Soc Trop Med Hyg; 1988; 82(5):743-4. PubMed ID: 3252594
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to medicines for orphan diseases: experience in the management of a case of Fasciola hepatica in Mumbai, Maharashtra, India.
    Thatte UM; Gogtay NJ; Sridharan K; Oak SN
    Natl Med J India; 2012; 25(4):234-5. PubMed ID: 23278785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Design of a Russian sample of the antifascioliasis antihelminthic triclabendazole and evaluation of its therapeutic efficiency].
    Mikhaĭlitsyn FS; Arkhipov IA; Eleev AB; Podushkin VIu; Sevbo DP
    Med Parazitol (Mosk); 2005; (4):38-9. PubMed ID: 16445238
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and therapeutic aspects of hepatic distomatosis].
    Monange C; Gisselbrecht H
    Therapeutique; 1971 May; 47(5):497-500. PubMed ID: 5562486
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of fascioliasis in human infections.
    Coles GC
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):187; author reply 187-8. PubMed ID: 16260013
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of human fascioliasis with triclabendazole.
    López-Vélez R; Domínguez-Castellano A; Garrón C
    Eur J Clin Microbiol Infect Dis; 1999 Jul; 18(7):525-6. PubMed ID: 10482035
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA permits use of liver fluke drug.
    J Am Vet Med Assoc; 1980 Feb; 176(4):297. PubMed ID: 7358546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic distomatosis due to "fasciola hepatica"; early diagnosis and treatment. Apropos of 30 cases].
    Delumeau G; Magois JY; Depagne A
    Arch Fr Mal App Dig; 1966 Sep; 55(9):826. PubMed ID: 5981231
    [No Abstract]   [Full Text] [Related]  

  • 20. [Praziquantel and other current preparations and chemotherapy methods in human trematodiases of the liver (opisthorchiasis and clonorchiasis) (a review of the literature)].
    Bronshteĭn AM
    Med Parazitol (Mosk); 1984; (6):51-6. PubMed ID: 6397686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.